AMCA
EW icon

Arthur M. Cohen & Associates’s Edwards Lifesciences EW Stock Holding History

Arthur M. Cohen & Associates’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$790K Sell
9,718
-2,065
-18% -$170K 0.14% 68
2025
Q4 		$1M Buy
11,783
+365
+3% +$30K 0.16% 65
2025
Q3 		$888K Sell
11,418
-1,265
-10% -$98.8K 0.15% 67
2025
Q2 		$992K Sell
12,683
-2,480
-16% -$185K 0.18% 64
2025
Q1 		$1.1M Sell
15,163
-4,295
-22% -$307K 0.21% 62
2024
Q4 		$1.44M Sell
19,458
-1,295
-6% -$90.6K 0.26% 51
2024
Q3 		$1.35M Sell
20,753
-980
-5% -$71.2K 0.24% 53
2024
Q2 		$2.01M Buy
21,733
+465
+2% +$41.2K 0.37% 38
2024
Q1 		$2.03M Buy
21,268
+60
+0.3% +$5.04K 0.43% 37
2023
Q4 		$1.62M Sell
21,208
-815
-4% -$56.7K 0.38% 42
2023
Q3 		$1.53M Buy
22,023
+662
+3% +$53.2K 0.39% 39
2023
Q2 		$2.01M Hold
21,361
– – 0.5% 31
2023
Q1 		$1.77M Buy
21,361
+623
+3% +$49K 0.47% 33
2022
Q4 		$1.55M Buy
20,738
+300
+1% +$23.1K 0.42% 31
2022
Q3 		$1.67M Sell
20,438
-825
-4% -$79.4K 0.46% 33
2022
Q2 		$2.02M Sell
21,263
-600
-3% -$62.1K 0.5% 33
2022
Q1 		$2.57M Sell
21,863
-755
-3% -$84.7K 0.54% 36
2021
Q4 		$2.94M Sell
22,618
-1,045
-4% -$122K 0.55% 34
2021
Q3 		$2.68M Hold
23,663
– – 0.54% 37
2021
Q2 		$2.45M Sell
23,663
-425
-2% -$40.1K 0.48% 40
2021
Q1 		$2.02M Buy
24,088
+220
+0.9% +$18.6K 0.46% 41
2020
Q4 		$2.18M Buy
23,868
+600
+3% +$49.8K 0.51% 39
2020
Q3 		$1.86M Sell
23,268
-2,700
-10% -$211K 0.48% 36
2020
Q2 		$1.79M Buy
25,968
+1,050
+4% +$74.6K 0.54% 32
2020
Q1 		$1.44M Buy
24,918
+240
+1% +$17.3K 0.57% 28
2019
Q4 		$1.92M Buy
24,678
+180
+0.7% +$14.1K 0.59% 31
2019
Q3 		$1.8K Sell
24,498
-240
-1% -$16.9K 0.51% 29
2019
Q2 		$1.52M Buy
24,738
+1,020
+4% +$61.7K 0.52% 29
2019
Q1 		$1.51M Buy
23,718
+1,200
+5% +$68.5K 0.54% 28
2018
Q4 		$1.15K Buy
22,518
+3,975
+21% +$201K 0.37% 37
2018
Q3 		$1.08K Hold
18,543
– – 0.33% 43
2018
Q2 		$890K Buy
18,543
+2,400
+15% +$112K 0.34% 45
2018
Q1 		$729K Sell
16,143
-6,375
-28% -$277K 0.28% 56
2017
Q4 		$1.15K Buy
+22,518
New +$826K 0.32% 36
2017
Q2 		$617K Sell
15,690
-810
-5% -$29.6K 0.24% 66
2017
Q1 		$515K Hold
16,500
– – 0.23% 60
2016
Q4 		$515K Buy
+16,500
New +$535K 0.27% 56
2014
Q3 		$568K Buy
+31,200
New +$493K 0.26% 66

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Arthur M. Cohen & Associates's EW Position: Q1 2026 in Review

Arthur M. Cohen & Associates reduced its Edwards Lifesciences (EW) stake by 18% in Q1 2026, selling an estimated $170K and leaving 9,718 shares worth $790K. The position accounts for 0.14% of the portfolio, ranked #68.

Arthur M. Cohen & Associates first reported a position in EW in Q3 2014 and has held it in 38 quarters since. The position peaked at $2.94M in Q4 2021. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Arthur M. Cohen & Associates held 9,718 shares of Edwards Lifesciences worth $790K as of Q1 2026.
  • Arthur M. Cohen & Associates sold 2,065 Edwards Lifesciences shares in Q1 2026, an estimated $170K.
  • Edwards Lifesciences made up 0.14% of Arthur M. Cohen & Associates's portfolio in Q1 2026, its #68 holding.
  • Arthur M. Cohen & Associates first reported a position in Edwards Lifesciences in Q3 2014 and has held it in 38 quarters since.
  • Arthur M. Cohen & Associates's Edwards Lifesciences position peaked at $2.94M in Q4 2021.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Arthur M. Cohen & Associates's 13F filing for Q1 2026, filed 8 May 2026.